Niacinamide Market Size, Share, Growth | CAGR of 5.1%

Overview

New York, NY – May 27, 2025 – The Global Niacinamide Market is set to grow significantly, with an expected value of USD 1075.5 million by 2034, up from USD 654.0 million in 2024, reflecting a steady CAGR of 5.1% from 2025 to 2034.

In 2024, the Powder Form led the Niacinamide Market’s By Form segment, securing a commanding 53.9% share. Its dominance is driven by rising demand in pharmaceuticals, cosmetics, and personal care products. Synthetic Niacinamide dominated the By Type segment of the Niacinamide Market in 2024, capturing a significant 91.5% share.

Pharmaceutical-Grade Niacinamide held a robust 67.4% share in the By Grade segment of the Niacinamide Market. Pharmaceuticals accounted for the largest share of the Niacinamide Market in 2024, representing 37.6% of the By Application segment. The extensive use of niacinamide in dietary supplements and therapeutic products for niacin deficiency drives its dominance.

US Tariff Impact on Niacinamide Market

The United States implemented a sweeping set of tariffs aimed at bolstering domestic manufacturing, significantly impacting the pharmaceutical and healthcare industries. A 10% tariff on nearly all imported goods, effective from April 5, 2025, has increased costs for critical healthcare items such as active pharmaceutical ingredients (APIs), medical devices, and equipment.

➤ Get More Detailed Insights about US Tariff Impact @ – https://market.us/report/global-niacinamide-market/request-sample/

Additionally, tariffs of up to 245% on Chinese APIs, including a 125% reciprocal tariff and a 20% fentanyl-related penalty, have disrupted the supply chain for generic drugs, which rely on Chinese APIs for approximately 40% of the U.S. supply. These measures, part of a broader effort to reduce the U.S. trade deficit, are driving up production costs, prompting companies to explore alternative suppliers or reshoring options, and risking shortages or delays in drug availability.

Furthermore, a 25% tariff on medical devices and materials from Canada and Mexico, unless compliant with the USMCA trade agreement, is adding financial strain, with companies like Boston Scientific projecting USD 200 million in additional costs. These policies are forcing pharmaceutical companies and healthcare providers to navigate higher operational costs, rethink global sourcing strategies, and address potential disruptions in patient access to essential treatments, ultimately impacting pricing and supply chains across the sector.

Key Takeaways

• Global Niacinamide Market is expected to be worth around USD 1,075.5 Million by 2034, up from USD 654.0 Million in 2024, and grow at a CAGR of 5.1% from 2025 to 2034.
• In the Niacinamide Market, powder form dominates with a substantial 53.9% share globally.
• Synthetic niacinamide accounts for a significant 91.5% of the total market share by type.
• Pharmaceutical grade niacinamide captures 67.4% of the market, driven by increasing medical applications.
• Pharmaceuticals hold a 37.6% share in the niacinamide market, emphasizing its therapeutic demand.
• Drug stores and retail pharmacies lead with a 54.8% distribution share, indicating strong consumer reach.
• The USD 298.2 Mn Niacinamide Market in North America reflects robust demand.

Report Scope

➤ Directly purchase a copy of the report – https://market.us/purchase-report/?report_id=147830

Key Market Segments

By Form Analysis

• In 2024, the Powder Form led the Niacinamide Market’s By Form segment, securing a commanding 53.9% share. Its dominance is driven by rising demand in pharmaceuticals, cosmetics, and personal care products. Powdered niacinamide’s extended shelf life and versatility in formulations like creams, serums, and dietary supplements bolster its market position.
• Growing consumer awareness of niacinamide’s skin-brightening and anti-aging benefits further fuels its use in skincare products. The pharmaceutical industry’s preference for powder due to its stability and ease of dosage measurement also supports its strong market share. With increasing interest in skin-enhancing and anti-inflammatory products, the powder segment is well-positioned for continued growth.

By Type Analysis

• Synthetic Niacinamide dominated the By Type segment of the Niacinamide Market in 2024, capturing a significant 91.5% share. Its widespread use in pharmaceuticals and cosmetics, driven by consistent quality and cost-effectiveness, underpins its market leadership. Synthetic niacinamide’s stability and reliable supply chain make it ideal for large-scale production of dietary supplements, skincare products, and pharmaceutical formulations. In pharmaceuticals, it is valued for its efficacy in treating niacin deficiency, while in cosmetics, its skin-brightening and anti-inflammatory properties make it a popular ingredient in serums, creams, and lotions, sustaining its dominant market position.

By Grade Analysis

• In 2024, Pharmaceutical-Grade Niacinamide held a robust 67.4% share in the By Grade segment of the Niacinamide Market. Its dominance stems from its widespread use in supplements, medications, and dermatological products, driven by high purity, regulatory compliance, and proven efficacy in treating niacin deficiency and skin conditions.
• The pharmaceutical industry’s demand for premium-grade niacinamide, particularly for nutritional tablets and capsules, significantly contributes to its market share. The rising prevalence of skin disorders and demand for anti-inflammatory and skin-brightening products further boost its use in topical formulations.

By Application Analysis

• Pharmaceuticals accounted for the largest share of the Niacinamide Market in 2024, representing 37.6% of the By Application segment. The extensive use of niacinamide in dietary supplements and therapeutic products for niacin deficiency drives its dominance. Its efficacy in treating skin conditions like acne, hyperpigmentation, and inflammation further strengthens its role in dermatological products.
• Niacinamide’s incorporation in anti-inflammatory and antioxidant formulations for both oral and topical applications supports its significant market share. Rising consumer demand for preventive healthcare and nutritional supplements continues to propel the growth of niacinamide-based pharmaceutical products.

Regional Analysis

• North America led the Niacinamide Market, capturing a 45.6% global share and generating USD 298.2 million in revenue. This dominance is fueled by strong consumer awareness of niacinamide’s skincare benefits and its extensive use in dietary supplements and cosmetics, particularly in the United States, where demand for anti-aging and skin-brightening products is high.
• Europe remains a key market, driven by growing applications in pharmaceuticals and nutraceuticals, supported by robust regulatory standards. The Asia Pacific region is experiencing steady growth, propelled by increased consumption of skincare products and dietary supplements in countries like China and India. Emerging markets in the Middle East & Africa and Latin America show promise, with rising consumer interest in health-enhancing supplements and niacinamide-infused beauty products.

Top Use Cases

• Skincare Products: Niacinamide is widely used in cosmetics for its skin-brightening and anti-aging benefits. It reduces dark spots, evens skin tone, and minimizes wrinkles. Popular in serums, creams, and lotions, it appeals to consumers seeking effective skincare solutions, driving demand in the beauty industry.
• Dietary Supplements: Niacinamide is a key ingredient in supplements to address niacin deficiency. It supports energy metabolism and overall health. Available in tablets and capsules, it meets the growing consumer demand for nutritional products, especially among health-conscious individuals.
• Pharmaceutical Formulations: In pharmaceuticals, niacinamide treats conditions like pellagra and skin disorders. Its anti-inflammatory properties make it valuable in topical and oral medications. The pharmaceutical sector values its stability and efficacy, boosting its use in therapeutic products.
• Nutraceuticals: Niacinamide is incorporated into nutraceutical products to enhance metabolic health and support skin wellness. Its antioxidant properties appeal to consumers seeking preventive healthcare. This use case is gaining traction in markets like Asia Pacific, where health supplements are increasingly popular.
• Animal Feed Additives: Niacinamide is added to animal feed to improve livestock health and growth. It supports metabolism and nutrient absorption in poultry and cattle. This application is growing in agricultural markets, particularly in regions focused on enhancing animal nutrition for better productivity.

Recent Developments

1. Aurorium (formerly Vertellus)

• Aurorium, a leading producer of niacinamide, has expanded its production capacity to meet growing global demand, particularly in skincare and pharmaceuticals. The company focuses on high-purity niacinamide for cosmetics and nutraceuticals, investing in sustainable manufacturing processes. Aurorium also emphasizes innovation in advanced formulations for anti-aging and brightening skincare products.

2. BASF SE

• BASF continues to strengthen its niacinamide portfolio with a focus on eco-friendly and high-performance ingredients. The company has introduced new niacinamide grades tailored for sensitive skin and enhanced stability in cosmetic formulations. BASF also collaborates with beauty brands to develop next-gen skincare solutions.

3. Brother Enterprises Holding Co. Ltd.

• A major Chinese supplier, Brother Enterprises, has scaled up niacinamide production to cater to the booming Asian beauty market. The company emphasizes cost-effective, high-quality niacinamide for cosmetics and dietary supplements, targeting both domestic and international markets.

4. DSM (now part of Firmenich)

• DSM-Firmenich has been innovating in niacinamide applications, particularly in microbiome-friendly skincare and personalized nutrition. The company’s research highlights niacinamide’s role in improving skin barrier function and reducing inflammation, driving demand in premium skincare lines.

5. Evonik Industries AG

• Evonik has developed novel niacinamide-based actives for anti-pollution and UV-protection skincare. The company also focuses on sustainable sourcing and green chemistry to align with global environmental standards, reinforcing its position in the premium cosmetics market.

Conclusion

The Niacinamide Market is thriving, driven by its versatile applications in skincare, pharmaceuticals, and dietary supplements. Its popularity in anti-aging and skin-brightening products, coupled with rising health awareness, fuels global demand. With strong growth in North America, Europe, and emerging markets like Asia Pacific, niacinamide’s market is set for continued expansion, supported by its efficacy and diverse uses.

Discuss Your Needs With Our Analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

Request a Sample Download PDF